Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3515)
INSMED Inc (INSM)
Lewis William — Director
Shares
254
Price
$160.70
Total Value
$40.82K
Shares Held After
306,891
% of Holdings
0.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,229
Price
$159.85
Total Value
$356.31K
Shares Held After
307,145
% of Holdings
0.7%
INSMED Inc (INSM)
Lewis William — Director
Shares
5,967
Price
$158.99
Total Value
$948.69K
Shares Held After
309,374
% of Holdings
1.9%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,243
Price
$158.37
Total Value
$196.85K
Shares Held After
315,341
% of Holdings
0.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,006
Price
$156.80
Total Value
$157.74K
Shares Held After
316,584
% of Holdings
0.3%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
972
Price
$8.92
Total Value
$8.67K
Shares Held After
8,321
% of Holdings
10.5%
Olema Pharmaceuticals, Inc. (OLMA)
Harmon Cyrus — Director
Shares
10,000
Price
$26.88
Total Value
$268.80K
Shares Held After
727,770
% of Holdings
1.4%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
75,000
Price
$7.88
Total Value
$590.93K
Shares Held After
3,091,604
% of Holdings
2.4%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
76,967
Price
$6.54
Total Value
$503.36K
Shares Held After
3,166,604
% of Holdings
2.4%
ImmunityBio, Inc. (IBRX)
Selecky Christobel — Director
Shares
25,000
Price
$7.51
Total Value
$187.65K
Shares Held After
0
% of Holdings
100.0%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
2,000
Price
$3.07
Total Value
$6.14K
Shares Held After
0
% of Holdings
100.0%
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
1,000
Price
$69.74
Total Value
$69.74K
Shares Held After
37,793
% of Holdings
2.6%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
12,432
Price
$4.80
Total Value
$59.67K
Shares Held After
629,943
% of Holdings
1.9%
Protagonist Therapeutics, Inc (PTGX)
MOLINA ARTURO MD — Chief Medical Officer
Shares
9,514
Price
$82.48
Total Value
$784.71K
Shares Held After
97,266
% of Holdings
8.9%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
34,438
Price
$82.48
Total Value
$2.84M
Shares Held After
580,505
% of Holdings
5.6%
Protagonist Therapeutics, Inc (PTGX)
Ali Asif — Chief Financial Officer
Shares
8,588
Price
$82.48
Total Value
$708.34K
Shares Held After
78,077
% of Holdings
9.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
600
Price
$1.32
Total Value
$792.00
Shares Held After
268,566
% of Holdings
0.2%
Apellis Pharmaceuticals, Inc. (APLS)
Baumal Caroline — Chief Medical Officer
Shares
1,882
Price
$19.79
Total Value
$37.25K
Shares Held After
89,324
% of Holdings
2.1%
Apellis Pharmaceuticals, Inc. (APLS)
Chopas James George — VP/Chief Accounting Officer
Shares
726
Price
$19.79
Total Value
$14.37K
Shares Held After
51,869
% of Holdings
1.4%
Apellis Pharmaceuticals, Inc. (APLS)
DeLong Mark Jeffrey — Chief Business & Strat Officer
Shares
1,334
Price
$19.79
Total Value
$26.40K
Shares Held After
81,724
% of Holdings
1.6%
Apellis Pharmaceuticals, Inc. (APLS)
Deschatelets Pascal — Chief Scientific Officer
Shares
909
Price
$19.79
Total Value
$17.99K
Shares Held After
1,157,310
% of Holdings
0.1%
Apellis Pharmaceuticals, Inc. (APLS)
Francois Cedric — Director
Shares
8,182
Price
$19.79
Total Value
$161.95K
Shares Held After
313,237
% of Holdings
2.5%
Apellis Pharmaceuticals, Inc. (APLS)
Nicholson Nur — Chief Technical Officer
Shares
2,203
Price
$19.79
Total Value
$43.60K
Shares Held After
78,843
% of Holdings
2.7%
Apellis Pharmaceuticals, Inc. (APLS)
Sullivan Timothy Eugene — Chief Financial Officer
Shares
2,892
Price
$19.79
Total Value
$57.24K
Shares Held After
104,188
% of Holdings
2.7%
Apellis Pharmaceuticals, Inc. (APLS)
Watson David O. — General Counsel
Shares
2,475
Price
$19.79
Total Value
$48.99K
Shares Held After
96,363
% of Holdings
2.5%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
10,000
Price
$27.34
Total Value
$273.42K
Shares Held After
90,270
% of Holdings
10.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Quan Joanne — CHIEF MEDICAL OFFICER
Shares
6,911
Price
$90.27
Total Value
$623.85K
Shares Held After
11,305
% of Holdings
37.9%
Beam Therapeutics Inc. (BEAM)
Cavanagh Bethany J — SVP, Finance and Treasurer
Shares
3,034
Price
$30.12
Total Value
$91.38K
Shares Held After
41,011
% of Holdings
6.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
416
Price
$32.10
Total Value
$13.35K
Shares Held After
50,437
% of Holdings
0.8%
Arcellx, Inc. (ACLX)
Lubner David Charles — Director
Shares
6,000
Price
$75.00
Total Value
$450.00K
Shares Held After
21,659
% of Holdings
21.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
3,760
Price
$18.42
Total Value
$69.27K
Shares Held After
50,897
% of Holdings
6.9%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
9,568
Price
$19.60
Total Value
$187.53K
Shares Held After
1,016,658
% of Holdings
0.9%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
8,484
Price
$19.60
Total Value
$166.29K
Shares Held After
900,292
% of Holdings
0.9%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
9,568
Price
$19.60
Total Value
$187.53K
Shares Held After
1,016,658
% of Holdings
0.9%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
8,484
Price
$19.60
Total Value
$166.29K
Shares Held After
900,292
% of Holdings
0.9%
Aura Biosciences, Inc. (AURA)
Elazzouzi Amy — Senior Vice President, Finance
Shares
1,581
Price
$4.86
Total Value
$7.68K
Shares Held After
84,081
% of Holdings
1.8%
Aura Biosciences, Inc. (AURA)
de los Pinos Elisabet — Director
Shares
16,928
Price
$4.86
Total Value
$82.27K
Shares Held After
457,463
% of Holdings
3.6%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
200
Price
$68.52
Total Value
$13.70K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
4,900
Price
$67.99
Total Value
$333.15K
Shares Held After
200
% of Holdings
96.1%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
400
Price
$66.68
Total Value
$26.67K
Shares Held After
5,100
% of Holdings
7.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Kelley Shannon T — General Counsel
Shares
429
Price
$501.40
Total Value
$215.10K
Shares Held After
8,481
% of Holdings
4.8%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Kelley Shannon T — General Counsel
Shares
263
Price
$490.77
Total Value
$129.07K
Shares Held After
8,910
% of Holdings
2.9%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
2,238
Price
$490.77
Total Value
$1.10M
Shares Held After
453,351
% of Holdings
0.5%
C4 Therapeutics, Inc. (CCCC)
REYNO LEONARD — Chief Medical Officer
Shares
10,000
Price
$2.22
Total Value
$22.20K
Shares Held After
156,382
% of Holdings
6.0%
ImmunityBio, Inc. (IBRX)
Selecky Christobel — Director
Shares
50,000
Price
$5.00
Total Value
$250.00K
Shares Held After
0
% of Holdings
100.0%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
8,406
Price
$44.48
Total Value
$373.88K
Shares Held After
100,558
% of Holdings
7.7%
Scholar Rock Holding Corp (SRRK)
Parlavecchio Caryn — CHRO
Shares
6,600
Price
$44.48
Total Value
$293.55K
Shares Held After
148,864
% of Holdings
4.2%
Scholar Rock Holding Corp (SRRK)
Marantz Jing L. — CHIEF MEDICAL OFFICER
Shares
5,798
Price
$44.48
Total Value
$257.88K
Shares Held After
95,687
% of Holdings
5.7%
Scholar Rock Holding Corp (SRRK)
Ho Junlin — GENERAL COUNSEL
Shares
8,016
Price
$44.48
Total Value
$356.53K
Shares Held After
214,553
% of Holdings
3.6%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
7,923
Price
$5.13
Total Value
$40.64K
Shares Held After
642,375
% of Holdings
1.2%
Showing 2301–2350 of 3515 transactions (page 47 of 71)